Abstract 570: Preclinical insights into 161Tb-trastuzumab and immune checkpoint combination therapy for cancer in a HER2-expressing murine cancer model
Sigrid Cold(University of Copenhagen), Lotte K. Kristensen, Emma Papin, Trine B. Engel, Andreas Kjær(University of Copenhagen), Jacob Hald(Imaging Center), Sebastian Gnosa(Linköping University), Pragalath Sadasivam, Myrto Ischyropoulou(Max Planck Institute of Experimental Medicine), Carsten H. Nielsen(Pertamina (Indonesia)), Sakeerthi K. Vinethkanth, Lene Jessen
Cited by 0
Related Papers
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging
|Neuroendocrinology|2017|495
Hyperpolarized 13C MRI: Path to Clinical Translation in Oncology
|Neoplasia|2018|446
Functional Imaging of Neuroendocrine Tumors: A Head-to-Head Comparison of Somatostatin Receptor Scintigraphy, <sup>123</sup>I-MIBG Scintigraphy, and <sup>18</sup>F-FDG PET
|Journal of Nuclear Medicine|2010|277
CD4<sup>+</sup> and CD8a<sup>+</sup> PET imaging predicts response to novel PD-1 checkpoint inhibitor: studies of Sym021 in syngeneic mouse cancer models
|Theranostics|2019|105
Expression of AEG-1 mRNA and protein in colorectal cancer patients and colon cancer cell lines
|Journal of Translational Medicine|2012|71